| Log in

Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

02 May, 2016

India and Southeast Asia-focused healthcare private equity firm Quadria Capital has picked up a stake in Ahmedabad-based drugmaker Concord Biotech Ltd, marking its third deal in In ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Quadria Capital backs Strand Life Sciences

Quadria Capital backs Strand Life Sciences

Joseph Rai 2 weeks ago
Strand Life Sciences Pvt. Ltd, which focuses on clinical genomics and...
Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Jyotindra Dubey 6 months ago
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20...
Quadria in advanced talks to invest in two SE Asian pharma companies

Quadria in advanced talks to invest in two SE Asian pharma companies

Lohit Jagwani 4 years ago
Singapore-headquartered private equity firm Quadria Capital is in advanced...
No Comments

Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

Powered by WordPress.com VIP